Astrana Health Appoints New CFO and Directors
Ticker: ASTH · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1083446
Sentiment: neutral
Topics: management-change, board-election, cfo-appointment
TL;DR
Astrana Health shakes up leadership with a new CFO and two board members.
AI Summary
Astrana Health, Inc. announced on March 26, 2025, significant changes in its board and executive team. The company elected two new directors, Dr. David L. Chen and Mr. Robert L. W. Smith, and appointed Mr. Jianping Wang as Chief Financial Officer. These changes are effective immediately.
Why It Matters
The appointment of a new CFO and directors can signal a strategic shift or a response to performance issues, potentially impacting the company's future direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Astrana Health, Inc. (company) — Registrant
- Dr. David L. Chen (person) — Newly Elected Director
- Mr. Robert L. W. Smith (person) — Newly Elected Director
- Mr. Jianping Wang (person) — Appointed Chief Financial Officer
- March 26, 2025 (date) — Date of earliest event reported
FAQ
Who were the new directors elected to the board of Astrana Health?
Dr. David L. Chen and Mr. Robert L. W. Smith were elected as new directors.
Who has been appointed as the new Chief Financial Officer?
Mr. Jianping Wang has been appointed as the new Chief Financial Officer.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated March 26, 2025.
What was Astrana Health's former company name?
Astrana Health, Inc. was formerly known as Apollo Medical Holdings, Inc. and SICLONE INDUSTRIES INC.
In which state was Astrana Health, Inc. incorporated?
Astrana Health, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 by Dr. David L. Chen regarding Astrana Health, Inc. (ASTH).